ELOXX PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.20% for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-12.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2021-03-12
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2018 was -0.20%.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was 0.00%, a 100.00% decline from fiscal 2016.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was 17.10%.
- ELOXX PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2015 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month |
|---|---|
| 2018-12-31 | -0.20% 10-K · filed 2021-03-12 |
| 2017-06-30 | 0.00% 10-K · filed 2017-10-13 |
| 2016-06-30 | 17.10% 10-K · filed 2017-10-13 |
| 2015-06-30 | 0.00% 10-K · filed 2017-10-13 |
| 2014-06-30 | 0.00% 10-K · filed 2016-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |